PRRT Treatment Center Rotterdam is the internationally renowned treatment and knowledge center for PRRT (Peptide Receptor Radionuclide Therapy). We focus on lengthening and improving the quality of life of patients with neuroendocrine tumors. Physicians can also find specific knowledge and information at our center. Read more about the Treatment Center.
A patient with a neuroendocrine tumor (NET) has a rare form of cancer. The treatment at our center consists of the administration of the radioactive labeled protein lutetium octreotate. In this way it is possible to treat these tumors with precision. Due to this focused treatment patients often experience a relief of symptoms, leading to an improved quality of life.
In order to qualify for Peptide Receptor Radionuclide Therapy the patient must meet specific criteria. The result of the treatment partly depends on the incorporation of the radioactive protein through the receptors on the tumor. Read more about PRRT treatment.
Receptor Radionuclide Therapy was developed in the PRRT Treatment Center and our treatment center continues to be one of the few Centers of Excellence in the world where this patient friendly method is applied. We are proud of the fact that since 2000 we have treated more than 1300 national and international patients, often with good results. The staff at PRRT Treatment Center Rotterdam remain committed to improving the quality of life of patients with NET.
Patients rate our complete treatment with an 8,9
Improving Quality of Life
The PRRT Treatment Center Rotterdam has set itself the goal to be known, both nationally and internationally, as a highly professional and patient friendly treatment center for PRRT treatment. For both patients and specialists we provide answers to questions, as well as up-to-date knowledge about this treatment.